Suchergebnisse
Suchergebnisse:
19. Mai 2021 · Because of the expertise of ophthalmologists like Drs. Caroline Minkus and Justin Yamanuha, University of Minnesota Physicians (M Physicians) is uniquely positioned to treat rare eye conditions––like uveitis––which require a collaborative, holistic approach that spans beyond just eye care.
15. Mai 2021 · Treating Uveitis, 2021: The State of the Art. Our understanding of this disease and tools for managing it continue to evolve. Clinicians offer an update. Like many ophthalmic problems, uveitis can be a challenge for clinicians.
5. Jan. 2023 · General recommendations of note in this guideline centre on tight monitoring of children with uveitis; the authors suggest every 3 months for stable, treated uveitis and monthly for patients tapering treatment. Specific treatment recommendations include using prednisolone acetate 1% over alternative topical preparations, and using ...
- 10.1136/bmjophth-2022-001091
- 2023
- BMJ Open Ophthalmol. 2023; 8(1): e001091.
7. Aug. 2017 · Here are the steps physicians take when managing a newly diagnosed uveitis patient. First, physicians say to first make sure that you’re dealing with a non-infectious uveitis. “My general approach is to first rule out infection with some targeted lab testing based on the patient’s history and ophthalmic exam,” explains Sam ...
Choices for therapy must be individualized based on multiple factors, including the patient’s history, underlying cause of uveitis, and any systemic diseases. Withdrawal of NCSIT should be individualized based on tolerance of the current treatment, duration of disease control, and the specific cause of uveitis.
8. Mai 2024 · Credit: Getty Images A team of ophthalmologists with the University of Nebraska Medical Center reviewed the research revealing how a multidisciplinary approach to care can benefit patients with uveitis and ease the burden on physicians.
22. Sept. 2014 · Update on drugs currently in development stages for uveitis treatment. Therapeutic agents are very rarely developed for the primary purpose of treating ocular inflammatory disease; instead, most advances in treatment occur when drugs previously used to successfully manage systemic inflammatory diseases are adapted for use in ...
